Evidence map›Paper›PMID 35711362›Full record

ReviewFrontiers in cardiovascular medicine2022

Repostioning of Telemedicine in Cardiovascular World Post-COVID-19 Pandemic.

Kamal Sharma, Zeel Patel, Smeet Patel, Kalpen Patel, Shweta Dabhi, Jinish Doshi, MohmadSabir Amdani, Darshini Shah, Dhyanee Patel, Ashwati Konat

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Kamal SharmaSAL Hospital, Ahmedabad, India.
Zeel PatelAmdavad Municipal Corporation (AMC) Medical Education Trust Medical College, Ahmedabad, India.
Smeet PatelSmt. Nathiba Hargovandas Lakhmichand (N.H.L.) Municipal Medical College, Ahmedabad, India.
Kalpen PatelPandit Deendayal Upadhyay (P.D.U) Medical College, Rajkot, India.
Shweta DabhiAmdavad Municipal Corporation (AMC) Medical Education Trust Medical College, Ahmedabad, India.
Jinish DoshiAmdavad Municipal Corporation (AMC) Medical Education Trust Medical College, Ahmedabad, India.
MohmadSabir AmdaniAmdavad Municipal Corporation (AMC) Medical Education Trust Medical College, Ahmedabad, India.
Darshini ShahGujarat Cancer Society (GCS) Medical College, Ahmedabad, India.
Dhyanee PatelAll India Institute of Medical Sciences Jodhpur, Jodhpur, India.
Ashwati KonatDepartment of Zoology, Biomedical Technology and Human Genetics, Gujarat University, Ahmedabad, India.
All India Institute of Medical Sciences Jodhpur · INGujarat Cancer Society · INGujarat University · INSmt. N.H.L. Municipal Medical College · INSterling Hospitals · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: During the COVID-19 pandemic, telemedicine is a quickest expanding service solution to provide improved access to sophisticated healthcare that is efficient, cost-effective, and time-consuming. Methods: This analysis is evaluated on the basis of several studies that look at the history, benefits, various techniques, challenges, uses, and impact of telemedicine in the treatment of heart failure and cardiac rehabilitation as during COVID-19 outbreak. Results: Patients avoided or refused medical treatment during COVID-19 pandemic despite the risk of illness and the threat of infections spreading. Telemedicine has become a non-traditional form of care delivery due to better access and high-end technologies such as virtual consultations, face-to-face video, smartphone visits, two-way text communication, distant patient history, and distal characteristic assessment. Remote monitoring can help manage cardiovascular disease risk factors and increase patient participation in blood pressure, heart failure data, and workout or other activity progress. Conclusion: Based on the findings of past studies, we can infer that telemedicine is still an emerging subject in the treatment and management of cardiovascular disease. Telemedicine and similar technologies will also revolutionize healthcare services by expanding their reach and providing a big pool of database for better research and analysis.

Indexed as

advantagescardiovascular diseasechallengesCOVID-19telemedicine

Identifiers

PMID35711362
PMCPMC9196028
OpenAlexW4281687455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.